Genuine Parts Co. (GPC) Falls 2.55% for January 13

Equities Staff |

One of the S&P 500’s big losers for Wednesday January 13 was Genuine Parts Co. (GPC). The company’s stock fell 2.55% to $77.61 on volume of 692,267 shares.

The stock opened the day at 79.92 and traded between a low of $77.34 and a high of $80.06. The stock finished the day down $2.03 per share. Genuine Parts Co. has an average daily volume of 764,301 and a total float of 150.76 million shares. The 50-day SMA for Genuine Parts Co. is $87.29 and its 200-day SMA is $87.81. The high for the stock over the last 52 weeks is $99.48 and the low is $78.13.

Genuine Parts Co is a service organization engaged in the distribution of automotive replacement parts, industrial replacement parts, office products and electrical & electronic materials.

Genuine Parts Co. is centered in Atlanta, GA, and has 39,000 employees. Today’s trading day leaves the company with a market cap of $11.7 billion. The company has a P/S ratio of n/a, P/B ratio of 3.71, and a 27.1.

For a complete fundamental analysis analysis of Genuine Parts Co., check out Equities.com’s Stock Valuation Analysis report for GPC. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and…

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…